News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive February 2, 2022 Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences Archive February 1, 2022 Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call and Webcast on February 8, 2022 Archive January 24, 2022 Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session Archive January 10, 2022 Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate Milestones Archive January 3, 2022 Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference Archive December 21, 2021 Deciphera Announces Approval of QINLOCK® in the United Kingdom for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor Archive November 30, 2021 Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations Archive November 22, 2021 Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor Archive November 5, 2021 Deciphera Pharmaceuticals Announces Top-Line Results from the INTRIGUE Phase 3 Clinical Study Archive November 2, 2021 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results
Archive February 1, 2022 Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call and Webcast on February 8, 2022
Archive January 24, 2022 Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session
Archive January 10, 2022 Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate Milestones
Archive January 3, 2022 Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
Archive December 21, 2021 Deciphera Announces Approval of QINLOCK® in the United Kingdom for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Archive November 30, 2021 Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations
Archive November 22, 2021 Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Archive November 5, 2021 Deciphera Pharmaceuticals Announces Top-Line Results from the INTRIGUE Phase 3 Clinical Study
Archive November 2, 2021 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results
